Trenbolone acetate

Last updated

Trenbolone acetate
Trenbolone acetate.svg
Clinical data
Trade names Finajet, Finaplix, others
Other namesRU-1697; Trenbolone 17β-acetate; 19-Nor-δ9,11-testosterone 17β-acetate; Estra-4,9,11-trien-17β-ol-3-one 17β-acetate
Routes of
administration 		Intramuscular injection
Drug class Androgen; Anabolic steroid; Androgen ester; Progestogen
Pharmacokinetic data
Elimination half-life Intramuscular: 3 days [1]
Identifiers
  • [(8S,13S,14S,17S)-13-Methyl-3-oxo-2,6,7,8,14,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-17-yl] acetate
CAS Number
PubChem CID
DrugBank
ChemSpider
UNII
ChEMBL
CompTox Dashboard (EPA)
ECHA InfoCard 100.030.380 OOjs UI icon edit-ltr-progressive.svg
Chemical and physical data
Formula C20H24O3
Molar mass 312.409 g·mol−1
3D model (JSmol)
  • CC(=O)O[C@H]1CC[C@@H]2[C@@]1(C=CC3=C4CCC(=O)C=C4CC[C@@H]23)C
  • InChI=1S/C20H24O3/c1-12(21)23-19-8-7-18-17-5-3-13-11-14(22)4-6-15(13)16(17)9-10-20(18,19)2/h9-11,17-19H,3-8H2,1-2H3/t17-,18+,19+,20+/m1/s1
  • Key:CMRJPMODSSEAPL-FYQPLNBISA-N

Trenbolone acetate, sold under brand names such as Finajet and Finaplix among others, is an androgen and anabolic steroid (AAS) medication used in veterinary medicine, specifically to increase the profitability of livestock by promoting muscle growth in cattle. [2] [3] [4] [5] It is given by injection into muscle. [5] [2]

Contents

Side effects of trenbolone acetate include symptoms of masculinization like acne, increased body hair growth, scalp hair loss, voice changes, and increased sexual desire. [5] The drug is a synthetic androgen and anabolic steroid [6] and hence is an agonist of the androgen receptor (AR), the biological target of androgens like testosterone and dihydrotestosterone (DHT). [5] [2] [7] It has strong anabolic effects and highly androgenic effects, as well as potent progestogenic effects, and weak glucocorticoid effects. [5] [2] [7] [8] [9] Trenbolone acetate is an androgen ester and a short-lasting prodrug of trenbolone in the body.

Trenbolone acetate was discovered in 1963 and was introduced for veterinary use in the early 1970s. [5] [10] [11] In addition to its veterinary use, trenbolone acetate is used to improve physique and performance, for which purpose it is purchased from black market suppliers. [5] The drug is a controlled substance in many countries and so non-veterinary use is generally illicit. [5]

Uses

Veterinary uses

A single cartridge of Finaplix-H containing 10 implants. Each implant contains 10 small yellow pellets. (Image Adapted from Medi-Vet Animal Health, LLC (https://www.medi-vet.com/Finaplix-H-p/16301.html)). A single cartridge of Finaplix-H containing 10 implants. Each implant includes 10 small yellow pellets (one whole column in the above image) which contains 200mg of trenbolone acetate.jpg
A single cartridge of Finaplix-H containing 10 implants. Each implant contains 10 small yellow pellets. (Image Adapted from Medi-Vet Animal Health, LLC (https://www.medi-vet.com/Finaplix-H-p/16301.html)).

In the livestock industry, trenbolone acetate is more often called Finaplix. It was intentionally developed to promote androgen and gain muscle mass in cattle. Due to its properties, this allows livestock to grow as much muscle as possible before they are transported to a slaughterhouse.

Methyl cellulose and yellow dye are usually present in pellets given to livestock. A single dosage generally consists of ten pellets, and a package of Finaplix usually consists of one cartridge containing one hundred pellets. The medication is administered by subcutaneous injection into the posterior ear using an implanter gun. Finaplix is consistently implanted until the animal is ready to be slaughtered. There is no withholding period.[ clarification needed ] Due to the common practice of trenbolone acetate use in veterinary medicine, it is quite common to find traces of trenbolone metabolites in cattle worldwide. [10] [12]

Image showing the general area of the implantation of Finaplix-H pellets displayed on bovine ear. General area of the implantation of Finaplix- H pellets displayed on bovine ear.jpg
Image showing the general area of the implantation of Finaplix-H pellets displayed on bovine ear.

Non-medical uses

Bodybuilding

Trenbolone acetate has never been approved for use in humans and therefore guidelines for human consumption do not exist. [5] However, athletes and bodybuilders have been using trenbolone acetate as a physique- and performance-enhancing drug for decades. Some argue there are many benefits for bodybuilder's using trenbolone acetate as an AAS. Unlike exogenous testosterone, trenbolone acetate does not cause fluid retention, [10] so bodybuilders appear leaner; therefore, it is more commonly used during preparation for competitive events. Trenbolone acetate does not convert into an estrogenic metabolite; [10] thus there are no estrogenic side effects. [5] Trenbolone enanthate is a commonly used AAS and lasts much longer than trenbolone acetate with intramuscular injection. [5]

Medical uses

Trenbolone acetate was never approved for use in humans and hence has no medical uses. [5] However, as an AAS, it would be expected to be effective for treating indications in which other AAS are useful, such as androgen deficiency, wasting syndromes, muscle atrophy, and certain types of anemia. [5] [13]

Trenbolone hexahydrobenzylcarbonate was previously produced for human use by Negma Pharmaceuticals of France in 1.5 ml ampoules containing 76.2 mg of the steroid.[ citation needed ]

Side effects

Trenbolone acetate, like any other AAS, has many side effects. [7] [14] [15] Its strong androgenic properties stimulate virilization, [7] making it unsuitable for women pursuing physique or performance enhancement. [5] The side effects of trenbolone acetate are similar to other AAS; however, the negative side effects specific to trenbolone acetate are as follows:

Androgenic

Trenbolone acetate has androgenic activity. [16] [17] [18] Common side effects include oily skin, acne, seborrhea, increased facial or body hair growth, and accelerated scalp hair loss. [5] [7] [19] Severity of these side effects varies based on an individual's genetics. Men susceptible to hair loss have a higher chance of becoming permanently bald. [7] In women, voice deepening, hirsutism, clitoral enlargement, and general virilization may occur. [5]

Hypogonadism

Trenbolone acetate contributes greatly to development of muscle mass and feed efficiency; however, administration of any AAS suppresses natural testosterone production and therefore has the potential to cause hypogonadism. [5] [14] [19]

Cardiovascular

Administration of any AAS can lead to cardiovascular issues. [20] Trenbolone acetate can have a strongly negative impact on cholesterol levels by suppressing high-density lipoprotein (HDL) cholesterol production and stimulating low-density lipoprotein (LDL) cholesterol production. [21] When compared to oral AAS, trenbolone acetate exerts a stronger negative effect on cholesterol levels. [22]

"Tren cough"

The exact mechanisms underlying "tren cough" are not known; however, trenbolone acetate's androgenic effect activates a variety of lipid-like active compounds called prostaglandins, [23] many of which are inflammatory and vasoconstrictive. Prostaglandins act on two signaling pathways: cyclooxygenase (COX) (also known as prostaglandin-endoperoxide synthase) and lipoxygenase (LOX) (EC 1.13.11.34, EC 1.13.11.33, etc.). [24] The bradykinin peptide is well known to promote a cough reaction associated with ACE inhibitors prescribed for hypertension. [25] [ relevant? ]

Estrogenic and progestogenic

Trenbolone is not estrogenic; [5] therefore, use does not lead to excess fluid retention. [5] However, due to trenbolone's potent progestogenic activity (it binds with high affinity to the progesterone receptor), [10] [18] gynecomastia, characterized by development and swelling of breast tissue, [26] may occur.[ citation needed ]

Pharmacology

Pharmacodynamics

The administration of the trenbolone hormone promotes a direct anabolic effect on Androgen Receptor (AR) activity. AR activity facilitated by trenbolone contributes to an increase in IGF-1 and IGF-1R levels, which then enhances skeletal muscle protein accretion. Activation and proliferation of satellite cells then facilitate an increase in skeletal muscle growth. How the administration of the trenbolone hormone causes muscle growth.jpg
The administration of the trenbolone hormone promotes a direct anabolic effect on Androgen Receptor (AR) activity. AR activity facilitated by trenbolone contributes to an increase in IGF-1 and IGF-1R levels, which then enhances skeletal muscle protein accretion. Activation and proliferation of satellite cells then facilitate an increase in skeletal muscle growth.

Trenbolone acetate is a prodrug of trenbolone. [2] [5] Like other AAS, trenbolone is an agonist of the androgen receptor (AR) and hence has anabolic and androgenic activity as well as antigonadotropic activity. [5] [2] [8] [17] The potency of Trenbolone is not known, although it's often falsely believed to be five times high as that of testosterone. [28] [29] This is based on a book by William Llewellyn but has not been definitively proven. Trenbolone was never approved for human use, and therefore limited data on the subject exists. The relevant literature, is usually done in rats, which makes the 500/100 potency number inaccurate. Rats respond differently to androgens and are less sensitive to androgens. While some literature report a 5 fold higher potency, two other scientific reviews report a 3 fold higher potency, which makes it unclear as to how large the relative potency actually is. [30] [31] Trenbolone is an agonist of the progesterone receptor (PR), and in relation to this, has moderate to strong progestogenic activity. [5] [8] [17] Conversely, trenbolone acetate is not a substrate for aromatase and hence lacks estrogenic activity. [5] [2] [8] The compound also has weak glucocorticoid activity. [8] [9]

Similar to many other AAS, trenbolone acetate has the capability to produce insulin-like growth factor-1 (IGF-1). [32] [33] This naturally produced protein-based hormone affects every cell in the body of an organism and plays a large role in muscle recovery and rejuvenation. Extreme muscle growth and cell splitting compared is facilitated through trenbolone acetate administration when compared to other AAS. [32] The facilitation of IGF-1 plays a significant role in the functions and properties of the central nervous system, pulmonary system, muscle tissue, ligaments, cartilage, and tendons. [33]

Trenbolone acetate also has the ability to increase red blood cell count. With a larger amount of red blood cells, blood oxygenation is enhanced. This allows for enhanced muscular endurance and therefore promotes a faster rate of recovery. Trenbolone acetate is capable of inhibiting glucocorticoids such as cortisol.[ citation needed ] The properties of glucocorticoid are the opposite of androgens as muscle tissue depletion and fat gain is promoted. [34] Administration of trenbolone acetate aims at decreasing the production of glucocorticoid hormones. Trenbolone acetate’s contribution to feed efficiency, also known as nutrient efficiency is what makes it an attractive AAS used for agricultural purposes. Food is one of the most anabolic substances that any living organism can consume, and therefore with the administration of trenbolone acetate, every nutrient in the body becomes a lot more valuable. [35] This facilitates an organism's body that is exposed to the AAS to make better use of the nutrients already consumed. [10] [35]

Pharmacokinetics

The acetate ester of trenbolone acetate allows for slow release post injection. This ester gives trenbolone an activated elimination half-life of about 3 days. [1]

Chemistry

Trenbolone acetate, or trenbolone 17β-acetate, is a synthetic estrane steroid and a derivative of nandrolone (19-nortestosterone). [5] [36] [37] It is the C17β acetate ester of trenbolone, which itself is δ9,11-19-nortestosterone (δ9,11-19-NT) or estra-4,9,11-trien-17β-ol-3-one. [5] [36] [37] Other trenbolone esters include trenbolone enanthate, trenbolone hexahydrobenzylcarbonate, and trenbolone undecanoate. [5] [36] [37]

Structural properties of major anabolic steroid esters
Anabolic steroidStructureEsterRelative
mol. weight		Relative
AAS contentb		Durationc
PositionMoietyTypeLengtha
Boldenone undecylenate
Boldenone undecylenate.svg
C17β Undecylenic acid Straight-chain fatty acid111.580.63Long
Drostanolone propionate
Drostanolone propionate.svg
C17β Propanoic acid Straight-chain fatty acid31.180.84Short
Metenolone acetate
Metenolone acetate.svg
C17β Ethanoic acid Straight-chain fatty acid21.140.88Short
Metenolone enanthate
Metenolone enanthate.png
C17β Heptanoic acid Straight-chain fatty acid71.370.73Long
Nandrolone decanoate
Nandrolone decanoate.svg
C17β Decanoic acid Straight-chain fatty acid101.560.64Long
Nandrolone phenylpropionate
Nandrolone phenylpropionate.svg
C17β Phenylpropanoic acid Aromatic fatty acid– (~6–7)1.480.67Long
Trenbolone acetate
Trenbolone acetate.svg
C17β Ethanoic acid Straight-chain fatty acid21.160.87Short
Trenbolone enanthate d
Trenbolone enanthate.svg
C17β Heptanoic acid Straight-chain fatty acid71.410.71Long
Footnotes:a = Length of ester in carbon atoms for straight-chain fatty acids or approximate length of ester in carbon atoms for aromatic fatty acids. b = Relative androgen/anabolic steroid content by weight (i.e., relative androgenic/anabolic potency). c = Duration by intramuscular or subcutaneous injection in oil solution. d = Never marketed. Sources: See individual articles.

Structure–activity relationships

Trenbolone acetate is a modified form of nandrolone. [16] The structure of trenbolone acetate is a 19-nor classification, which represents a structural change of the testosterone hormone. Trenbolone acetate lacks a carbon atom at the 19 position and carries a double bond at carbons 9 and 11. The position of these carbons slows its metabolism, which greatly increases its binding affinity to the AR, and inhibits it from undergoing aromatization into the corresponding estrogenic metabolite. Trenbolone acetate contains trenbolone modified with the addition of a carboxylic acid ester (acetic acid) at the 17β-hydroxyl group. [10] This facilitates the slow release of the AAS from the area of injection.

History

Trenbolone acetate was first synthesized in 1963 and approved by the livestock industry as a growth promoter for beef cattle in the early 1970s. [5] [10] [11] During this period of its first administration, trenbolone acetate was sold under the names Finajet and Finaject. The original manufacturer of trenbolone acetate discontinued during the late 1980s and administered the synthesis of subcutaneous pellets called Finaplix. These pellets aimed to increase muscle mass and lean tissue of cattle prior to slaughter to increase the profitability of livestock when measured in total pounds of meat sold. [10]

The drug appears to have been an early development project of Roussel Uclaf, a French pharmaceutical company, and by the early 1970s, it was being sold as an injectable. [18] There are a number of trenbolone esters but trenbolone acetate is the only one known to be produced in veterinary AAS manufacturers.

Trenbolone acetate became popular among bodybuilders and athletes during the early 1980s. During this period, the AAS was transported illegally from Europe in large quantities. Although trenbolone acetate was very popular for a short amount of time, the large amounts of supplies were discontinued in 1987. [10] This decision was based upon the public concern of sports doping and its negative effects on athletes. [5]

Society and culture

Generic names

Trenbolone acetate is the generic name of the drug and its USAN Tooltip United States Adopted Name, USP Tooltip United States Pharmacopeia, and BANM Tooltip British Approved Name. [3] [4] [36] [37]

Brand names

Trenbolone acetate is or has been sold alone for veterinary use under the brand names Component TH, Component TS, Finaject, Finajet, Finaplix-H, and Finaplix-S. [3] [4] [5] [36] [37] It is or has also been sold in combination with estradiol or estradiol benzoate for veterinary use under the brand names Revalor and Synovex. [3] [4] [5] [36] [37]

Distribution and regulation

Trenbolone acetate, specifically referred to as Finaplix in the livestock industry, is available to purchase in veterinary drug markets. [5] A typical cartridge usually comes in the form of 20 mg pellets. It generally comes in the form of implant pellets containing 20 mg of trenbolone acetate each. [36] Preparations containing trenbolone acetate remain rare since its decline in production after the 1980s. Using AAS for any other purpose, or without a doctor's prescription, is illegal in most countries. Major sporting and bodybuilding organizations ban the use of controlled AAS, and the possession or sale of drugs can lead to arrest and conviction of drug-trafficking in many countries, including the United States and Australia. However, in the United Kingdom, owning AAS for personal use as a bodybuilding supplement is not illegal, but selling the AAS without a valid medical license or reason is still against the law. [38] [39]

Doping in sports

Regardless of their legality, AAS are still banned by most sporting leagues in the country, who routinely conduct drug tests to find the users of any AAS. There are known cases of doping in sports with trenbolone acetate by professional athletes.

Related Research Articles

<span class="mw-page-title-main">Tetrahydrogestrinone</span> Synthetic and orally active anabolic–androgenic steroid (AAS)

Tetrahydrogestrinone (THG), known by the nickname The Clear, is a synthetic and orally active anabolic–androgenic steroid (AAS) which was never marketed for medical use. It was developed by Patrick Arnold and was used by a number of high-profile athletes such as Barry Bonds and Dwain Chambers.

<span class="mw-page-title-main">Metenolone</span> Chemical compound

Metenolone, or methenolone, is an androgen and anabolic steroid (AAS) which is used in the form of esters such as metenolone acetate and metenolone enanthate. Metenolone esters are used mainly in the treatment of anemia due to bone marrow failure. Metenolone acetate is taken by mouth, while metenolone enanthate is given by injection into muscle.

<span class="mw-page-title-main">Nandrolone decanoate</span> Anabolic steroid

Nandrolone decanoate, sold under the brand names Rolon and Deca-Durabolin, among others, is an androgen and anabolic steroid (AAS) medication which is used primarily in the treatment of anemias and wasting syndromes, as well as osteoporosis in menopausal women. It is given by injection into muscle or fat once every one to four weeks.

<span class="mw-page-title-main">Trenbolone</span> Anabolic steroid

Trenbolone is an androgen and anabolic steroid (AAS) of the nandrolone group which itself was never marketed. Trenbolone ester prodrugs, including trenbolone acetate and trenbolone hexahydrobenzylcarbonate, are or have been marketed for veterinary and clinical use. Trenbolone acetate is used in veterinary medicine in livestock to increase muscle growth and appetite, while trenbolone hexahydrobenzylcarbonate was formerly used clinically in humans but is now no longer marketed. In addition, although it is not approved for clinical or veterinary use, trenbolone enanthate is sometimes sold on the black market under the nickname Trenabol.

<span class="mw-page-title-main">Testosterone cypionate</span> Chemical compound

Testosterone cypionate, sold under the brand name Depo-Testosterone among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels in men, including hormone therapy for transgender men. It is given by injection into muscle or subcutaneously, once every one to four weeks, depending on clinical indication.

<span class="mw-page-title-main">Ethylestrenol</span> Chemical compound

Ethylestrenol, also known as ethyloestrenol or ethylnandrol and sold under the brand names Maxibolin and Orabolin among others, is an androgen and anabolic steroid (AAS) medication which has been used in the past for a variety of indications such as to promote weight gain and to treat anemia and osteoporosis but has been discontinued for use in humans. It is still available for veterinary use in Australia and New Zealand however. It is taken by mouth.

<span class="mw-page-title-main">Mesterolone</span> Chemical compound

Mesterolone, sold under the brand name Proviron among others, is an androgen and anabolic steroid (AAS) medication which is used mainly in the treatment of low testosterone levels. It has also been used to treat male infertility, although this use is controversial. It is taken by mouth.

<span class="mw-page-title-main">Fluoxymesterone</span> Chemical compound

Fluoxymesterone, sold under the brand names Halotestin and Ultandren among others, is an androgen and anabolic steroid (AAS) medication which is used in the treatment of low testosterone levels in men, delayed puberty in boys, breast cancer in women, and anemia. It is taken by mouth.

<span class="mw-page-title-main">Trestolone</span> Chemical compound

Trestolone, also known as 7α-methyl-19-nortestosterone (MENT), is an experimental androgen/anabolic steroid (AAS) and progestogen medication which has been under development for potential use as a form of hormonal birth control for men and in androgen replacement therapy for low testosterone levels in men but has never been marketed for medical use. It is given as an implant that is placed into fat. As trestolone acetate, an androgen ester and prodrug of trestolone, the medication can also be given by injection into muscle.

<span class="mw-page-title-main">Selective androgen receptor modulator</span> Class of pharmaceutical drugs

Selective androgen receptor modulators (SARMs) are a class of drugs that selectively activate the androgen receptor in specific tissues, promoting muscle and bone growth while having less effect on male reproductive tissues like the prostate gland.

<span class="mw-page-title-main">Metribolone</span> Chemical compound

Metribolone is a synthetic and orally active anabolic–androgenic steroid (AAS) and a 17α-alkylated nandrolone (19-nortestosterone) derivative which was never marketed for medical use but has been widely used in scientific research as a hot ligand in androgen receptor (AR) ligand binding assays (LBAs) and as a photoaffinity label for the AR. More precisely, metribolone is the 17α-methylated derivative of trenbolone. It was investigated briefly for the treatment of advanced breast cancer in women in the late 1960s and early 1970s, but was found to produce signs of severe hepatotoxicity at very low dosages, and its development was subsequently discontinued.

<span class="mw-page-title-main">Anabolic steroid</span> Class of drugs

Anabolic steroids, also known as anabolic-androgenic steroids (AAS), are a class of drugs that are structurally related to testosterone, the main male sex hormone, and produce effects by binding to the androgen receptor (AR). Anabolic steroids have a number of medical uses, but are also used by athletes to increase muscle size, strength, and performance.

<span class="mw-page-title-main">Trenbolone enanthate</span> Chemical compound

Trenbolone enanthate, known by the nickname Trenabol, is a synthetic and injected anabolic–androgenic steroid (AAS) and a derivative of nandrolone which was never marketed. It is the C17β enanthate ester and a long-acting prodrug of trenbolone. Trenbolone enanthate was never approved for medical or veterinary use but is used in scientific research and has been sold on the internet black market as a designer steroid for bodybuilders and athletes.

<span class="mw-page-title-main">Nandrolone phenylpropionate</span> Anabolic steroid

Nandrolone phenylpropionate (NPP), or nandrolone phenpropionate, sold under the brand name Durabolin among others, is an androgen and anabolic steroid (AAS) medication which has been used primarily in the treatment of breast cancer and osteoporosis in women. It is given by injection into muscle once every week. Although it was widely used in the past, the drug has mostly been discontinued and hence is now mostly no longer available.

<span class="mw-page-title-main">Dimethandrolone</span> Chemical compound

Dimethandrolone (DMA), also known by its developmental code name CDB-1321, is an experimental androgen/anabolic steroid (AAS) and progestogen medication which is under investigation for potential clinical use.

<span class="mw-page-title-main">Trenbolone hexahydrobenzylcarbonate</span> Chemical compound

Trenbolone hexahydrobenzylcarbonate, or trenbolone cyclohexylmethylcarbonate, sold under the brand names Parabolan and Hexabolan, is a synthetic, injected anabolic–androgenic steroid (AAS) of the nandrolone group and an androgen ester – specifically, the C17β hexahydrobenzylcarbonate (cyclohexylmethylcarbonate) ester of trenbolone – which was marketed in France for medical use in humans but has since been discontinued.

<span class="mw-page-title-main">Dimethandrolone undecanoate</span> Chemical compound

Dimethandrolone undecanoate (DMAU), also known by its developmental code name CDB-4521, is an experimental androgen/anabolic steroid (AAS) and progestogen medication which is under development as a potential birth control pill for men. It is taken by mouth, but can also be given by injection into muscle.

<span class="mw-page-title-main">Trenbolone undecanoate</span> Chemical compound

Trenbolone undecanoate, or trenbolone undecylate, is a synthetic and injected anabolic–androgenic steroid (AAS) and a derivative of nandrolone (19-nortestosterone) which was never marketed. It is the C17β undecanoate (undecylate) ester and a long-acting prodrug of trenbolone. The drug was described by Roussel Uclaf in 1967 and was the first long-lasting ester of trenbolone to be developed. Subsequently, trenbolone hexahydrobenzylcarbonate, a roughly equivalent compound, was developed and introduced for use in humans in 1980, though it was discontinued in 1997. Trenbolone enanthate is another long-lasting ester of trenbolone. Similarly to trenbolone undecanoate, it was never marketed, but it has been sold on the black market as a designer steroid for bodybuilders and athletes.

<span class="mw-page-title-main">Trendione</span> Chemical compound

Trendione, also known as estra-4,9,11-triene-3,17-dione, is an androgen prohormone as well as metabolite of the anabolic steroid trenbolone. Trendione is to trenbolone as androstenedione is to testosterone. The compound is inactive itself, showing more than 100-fold lower affinity for the androgen and progesterone receptors than trenbolone. It is a designer steroid and has been sold on the internet as a "nutritional supplement". Trendione is listed in the United States Designer Anabolic Steroid Control Act of 2014.

References

  1. 1 2 Ruiz P, Strain EC (2011). Lowinson and Ruiz's Substance Abuse: A Comprehensive Textbook. Lippincott Williams & Wilkins. pp. 358–. ISBN   978-1-60547-277-5.
  2. 1 2 3 4 5 6 7 Yarrow JF, McCoy SC, Borst SE (June 2010). "Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity". Steroids. 75 (6): 377–389. doi:10.1016/j.steroids.2010.01.019. PMID   20138077. S2CID   205253265.
  3. 1 2 3 4 Morton IK, Hall JM (6 December 2012). Concise Dictionary of Pharmacological Agents: Properties and Synonyms. Springer Science & Business Media. pp. 279–. ISBN   978-94-011-4439-1.
  4. 1 2 3 4 "Trenbolone". Archived from the original on 2020-07-07. Retrieved 2017-11-11.
  5. 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 Llewellyn W (2011). Anabolics. Molecular Nutrition Llc. pp. 491–499. ISBN   978-0-9828280-1-4.
  6. ↑ Zarkawi M, Galbraith H, Hutchinson JS (April 1991). "The action of trenbolone acetate, a synthetic anabolic steroid, on ovarian function in the guinea pig". Laboratory Animals. 25 (2): 117–121. doi:10.1258/002367791781082586. PMID   1857092. S2CID   31765638.
  7. 1 2 3 4 5 6 Kicman AT (June 2008). "Pharmacology of anabolic steroids". British Journal of Pharmacology. 154 (3): 502–521. doi:10.1038/bjp.2008.165. PMC   2439524 . PMID   18500378.
  8. 1 2 3 4 5 Meyer HH, Rapp M (1985). "Reversible binding of the anabolic steroid trenbolone to steroid receptors". European Journal of Endocrinology. 110 (1 Suppla): S129–S130. doi:10.1530/acta.0.109S129. ISSN   0804-4643.
  9. 1 2 Delettré J, Mornon JP, Lepicard G, Ojasoo T, Raynaud JP (January 1980). "Steroid flexibility and receptor specificity". Journal of Steroid Biochemistry. 13 (1): 45–59. doi:10.1016/0022-4731(80)90112-0. PMID   7382482.
  10. 1 2 3 4 5 6 7 8 9 10 Robinson JA, Ma Q, Staveley JP, Smolenski WJ, Ericson J (March 2017). "Degradation and transformation of 17α-trenbolone in aerobic water-sediment systems". Environmental Toxicology and Chemistry. 36 (3): 630–635. doi:10.1002/etc.3381. PMID   26800846. S2CID   4706788.
  11. 1 2 Durhan EJ, Lambright CS, Makynen EA, Lazorchak J, Hartig PC, Wilson VS, et al. (April 2006). "Identification of metabolites of trenbolone acetate in androgenic runoff from a beef feedlot". Environmental Health Perspectives. 114 (S-1): 65–68. doi:10.1289/ehp.8055. PMC   1874171 . PMID   16818248.
  12. ↑ Jeong SH, Kang D, Lim MW, Kang CS, Sung HJ (December 2010). "Risk assessment of growth hormones and antimicrobial residues in meat". Toxicological Research. 26 (4): 301–313. doi:10.5487/TR.2010.26.4.301. PMC   3834504 . PMID   24278538.
  13. ↑ Basaria S, Wahlstrom JT, Dobs AS (November 2001). "Clinical review 138: Anabolic-androgenic steroid therapy in the treatment of chronic diseases". The Journal of Clinical Endocrinology and Metabolism. 86 (11): 5108–5117. doi: 10.1210/jcem.86.11.7983 . PMID   11701661.
  14. 1 2 Spranger B, Metzler M (April 1991). "Disposition of 17 beta-trenbolone in humans". Journal of Chromatography. 564 (2): 485–492. doi:10.1016/0378-4347(91)80517-G. PMID   1874853.
  15. ↑ "Trenbolone Acetate - A comprehensive list of side effects". trenacetate.biz. 21 June 2020. Retrieved 2021-02-22.
  16. 1 2 Gasparini M, Curatolo M, Assini W, Bozzoni E, Tognoli N, Dusi G (November 2009). "Confirmatory method for the determination of nandrolone and trenbolone in urine samples using immunoaffinity cleanup and liquid chromatography-tandem mass spectrometry". Journal of Chromatography A. 1216 (46): 8059–8066. doi:10.1016/j.chroma.2009.04.075. PMID   19447393.
  17. 1 2 3 Bauer ER, Daxenberger A, Petri T, Sauerwein H, Meyer HH (December 2000). "Characterisation of the affinity of different anabolics and synthetic hormones to the human androgen receptor, human sex hormone binding globulin and to the bovine progestin receptor". APMIS. 108 (12): 838–846. doi:10.1111/j.1600-0463.2000.tb00007.x. PMID   11252818. S2CID   22776408.
  18. 1 2 3 Richold M (1988). "The genotoxicity of trenbolone, a synthetic steroid". Archives of Toxicology. 61 (4): 249–258. doi:10.1007/BF00364846. PMID   3288174. S2CID   8804818.
  19. 1 2 Sillence MN, Rodway RG (September 1990). "Effects of trenbolone acetate and testosterone on growth and on plasma concentrations of corticosterone and ACTH in rats". The Journal of Endocrinology. 126 (3): 461–466. doi:10.1677/joe.0.1260461. PMID   2170557.
  20. ↑ Payne JR, Kotwinski PJ, Montgomery HE (May 2004). "Cardiac effects of anabolic steroids". Heart. 90 (5): 473–475. doi:10.1136/hrt.2003.025783. PMC   1768197 . PMID   15084526.
  21. ↑ Donner DG, Elliott GE, Beck BR, Bulmer AC, Lam AK, Headrick JP, et al. (January 2016). "Trenbolone Improves Cardiometabolic Risk Factors and Myocardial Tolerance to Ischemia-Reperfusion in Male Rats With Testosterone-Deficient Metabolic Syndrome". Endocrinology. 157 (1): 368–381. doi: 10.1210/en.2015-1603 . PMID   26584015.
  22. ↑ Shahsavari Nia K, Rahmani F, Ebrahimi Bakhtavar H, Hashemi Aghdam Y, Balafar M (2014). "A Young Man with Myocardial Infarction due to Trenbolone Acetate; a Case Report". Emergency. 2 (1): 43–45. PMC   4614617 . PMID   26495342.
  23. ↑ Notelovitz M (April 2002). "Androgen effects on bone and muscle". Fertility and Sterility. 77 (Suppl 4): S34–S41. doi: 10.1016/S0015-0282(02)02968-0 . PMID   12007900.
  24. ↑ Kam PC, See AU (May 2000). "Cyclo-oxygenase isoenzymes: physiological and pharmacological role". Anaesthesia. 55 (5): 442–449. doi: 10.1046/j.1365-2044.2000.01271.x . PMID   10792135. S2CID   21643058.
  25. ↑ Fox AJ, Lalloo UG, Belvisi MG, Bernareggi M, Chung KF, Barnes PJ (July 1996). "Bradykinin-evoked sensitization of airway sensory nerves: a mechanism for ACE-inhibitor cough". Nature Medicine. 2 (7): 814–817. doi:10.1038/nm0796-814. PMID   8673930. S2CID   6040673.
  26. ↑ Johnson RE, Murad MH (November 2009). "Gynecomastia: pathophysiology, evaluation, and management". Mayo Clinic Proceedings. 84 (11): 1010–1015. doi:10.4065/84.11.1010. PMC   2770912 . PMID   19880691.
  27. ↑ Wilson VS, Lambright C, Ostby J, Gray LE (December 2002). "In vitro and in vivo effects of 17beta-trenbolone: a feedlot effluent contaminant". Toxicological Sciences. 70 (2): 202–211. doi: 10.1093/toxsci/70.2.202 . PMID   12441365.
  28. ↑ Llewellyn W (2011). Anabolics. Molecular Nutrition Llc. ISBN   978-0-9828280-1-4.
  29. ↑ Wiebe JP (2011-01-13). "The microenvironment in health and cancer of the mammary gland". In Mascie-Taylor CG, Rosetta L (eds.). Reproduction and Adaptation: Topics in Human Reproductive Ecology. Cambridge University Press. p. 69. ISBN   978-1-139-49430-4.
  30. ↑ Neumann F (1976). "Pharmacological and endocrinological studies on anabolic agents". Environmental Quality and Safety. Supplement (5): 253–264. PMID   782871.
  31. ↑ Yarrow JF, McCoy SC, Borst SE (June 2010). "Tissue selectivity and potential clinical applications of trenbolone (17beta-hydroxyestra-4,9,11-trien-3-one): A potent anabolic steroid with reduced androgenic and estrogenic activity". Steroids. 75 (6): 377–389. doi:10.1016/j.steroids.2010.01.019. PMID   20138077.
  32. 1 2 Kamanga-Sollo E, White ME, Hathaway MR, Chung KY, Johnson BJ, Dayton WR (July 2008). "Roles of IGF-I and the estrogen, androgen and IGF-I receptors in estradiol-17beta- and trenbolone acetate-stimulated proliferation of cultured bovine satellite cells". Domestic Animal Endocrinology. 35 (1): 88–97. doi:10.1016/j.domaniend.2008.02.003. PMID   18403176.
  33. 1 2 Sinnett-Smith PA, Dumelow NW, Buttery PJ (September 1983). "Effects of trenbolone acetate and zeranol on protein metabolism in male castrate and female lambs". The British Journal of Nutrition. 50 (2): 225–234. doi: 10.1079/BJN19830092 . PMID   6193805.
  34. ↑ Coutinho AE, Chapman KE (March 2011). "The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights". Molecular and Cellular Endocrinology. 335 (1): 2–13. doi:10.1016/j.mce.2010.04.005. PMC   3047790 . PMID   20398732.
  35. 1 2 Griffiths TW (2010). "Effects of trenbolone acetate and resorcylic acid lactone on protein metabolism and growth in steers". Animal Production. 34 (3): 309–314. doi:10.1017/S0003356100010254. ISSN   0003-3561.
  36. 1 2 3 4 5 6 7 Elks J (14 November 2014). The Dictionary of Drugs: Chemical Data: Chemical Data, Structures and Bibliographies. Springer. ISBN   978-1-4757-2085-3.
  37. 1 2 3 4 5 6 Index Nominum 2000: International Drug Directory. Taylor & Francis. January 2000. p. 1591. ISBN   978-3-88763-075-1.
  38. ↑ "Anabolic Steroids".
  39. ↑ "Trenbolone Acetate 100 Norma".

Further reading

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.